Table 2.
The change of the parameters of the participant before and after treatment.
| Variable | Liposomal iron | IV iron dextran | p value | ||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
|
Hb (g/dl) |
10.09 ± 1.38 | 11.68 ± 2.12 | 10.56 ± 1.58 | 11.17 ± 1.65 | 0.096 |
| 0.001** | 0.065 | ||||
|
RBCS (cellx106/uL) |
3.68 ± 0.70 | 4.22 ± 0.89 | 3.98 ± 0.69 | 4.07 ± 0.77 | 0.756 |
| 0.001** | 0.499 | ||||
|
PLTs (cell ×103/uL) |
272.33 ± 90.89 | 274.53 ± 107.43 | 319.03 ± 124.55 | 291.8 ± 162.43 | 0.135 |
| 0.885 | 0.30* | ||||
|
HCT (%) |
31.16 ± 5.37 | 34.46 ± 7.41 | 33.27 ± 5.4 | 35.52 ± 4.94 | 0.504 |
| 0.003* | 0.051 | ||||
|
MCV (fL) |
82.29 ± 7.02 | 85.02 ± 8.76 | 83.567 ± 5.56 | 85.17 ± 6.16 | 0.188 |
| 0.006* | 0.032* | ||||
|
RDW-CV (%) |
15.42 ± 1.26 | 16.61 ± 1.45 | 15.19 ± 1.33 | 16.31 ± 1.84 | 0.001** |
| 0.001** | 0.002* | ||||
|
Cr (mg/dl) |
6.79 ± 2.37 | 7.37 ± 2.45 | 7.17 ± 2.19 | 7.72 ± 2.23 | 0.096 |
| 0.105 | 0.115 | ||||
|
Hepecidin (pg/mL) |
1357.52 ± 336.93 | 202.17 ± 127.01 | 801.17 ± 181.43 | 179.17 ± 99.48 | 0.756 |
| 0.001** | 0.001** | ||||
|
Ferritin (ng/ml) |
407.48 ± 421.37 | 241.14 ± 174.54 | 387.63 ± 344.64 | 398.8 ± 402.78 | 0.135 |
| 0.002* | 0.184 | ||||
|
Iron (ug/dl) |
54.40 ± 24.92 | 78.39 ± 39.15 | 63.79 ± 16.56 | 80.66 ± 42.47 | 0.504 |
| 0.001** | 0.014* | ||||
|
TIBC (ug/dl) |
191.57 ± 82.05 | 252.3 ± 90.76 | 245.83 ± 48.64 | 286.87 ± 46.93 | 0.188 |
| 0.001** | 0.002* | ||||
|
Transferrin (mg/dl) |
166.07 ± 31.22 | 193.13 ± 39.02 | 178.73 ± 34.49 | 182.53 ± 43.05 | 0.001** |
| 0.001** | 0.226 | ||||
Data are presented as mean ± SD, significant P < 0.05 (*) and highly significant P < 0.001 (**).
N.B Serum creatinine for hemodialysis patients was measured pre-dialysis.
Hb hemoglobin, RBCs red blood cells, PLTs platelets, HCT hematocrit, MCV mean corpuscular volume, RDW-CV red cell distribution width - coefficient of variation, Cr creatinine, TIBC Total iron binding capacity.